Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PUBLIC EMPLOYEES' RETIREMENT SYSTEM OF MISSISSIPPI v. MYLAN N.V. et al
Case Number:
2:20-cv-00955
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bernstein Litowitz
- Davidson Bowie
- Flannery Georgalis
- Freedman Normand
- Kessler Topaz
- Pietragallo Gordon
- Weiss Burkardt
- Wilson Sonsini
Companies
Sectors & Industries:
-
July 08, 2025
Mylan Securities Class Action Over W.Va. Plant Will Proceed
A Pennsylvania federal judge on Tuesday denied a win for former pharmaceutical company Mylan NV in a proposed shareholder class action accusing the company of manipulating quality control tests at a West Virginia plant, saying the plaintiff has met the burden of showing a link between misrepresentations and financial losses.
-
May 19, 2023
Mylan Beats Most Claims In Investor Suit Over W.Va. Plant
A Pennsylvania federal judge cut down a proposed stockholder class action against pharmaceutical company Mylan NV that alleges it artificially increased its stock price by manipulating quality control tests at a West Virginia plant, ruling that several of the alleged misrepresentations included in the complaint are not actionable.
-
March 14, 2023
Mylan Execs Were Unaware Of W.Va. Plant Issues, Court Told
Former executives at Mylan NV didn't have personal knowledge of quality control or regulatory issues at a West Virginia pharmaceutical plant, nor did they have a duty to tell investors all the details when the U.S. Food and Drug Administration stepped in, counsel for the company told a Pennsylvania federal judge Tuesday.
-
January 20, 2021
Mylan Wants Out Of Investor Suit Over FDA Inspections
Pharmaceutical company Mylan NV told a Pennsylvania federal judge Tuesday he should toss a proposed class action alleging securities fraud because the company made "unvarnished disclosures" about its quality assurance and compliance with the U.S. Food and Drug Administration's regulations.
-
September 15, 2020
Bernstein Litowitz, Kessler Topaz Lead Mylan Stock-Drop Suit
The law firms of Bernstein Litowitz and Kessler Topaz will lead a proposed investor class-action lawsuit brought by Mississippi retirees against Mylan NV over allegedly falsified quality controls at a West Virginia plant, a Pennsylvania federal judge said.
-
June 29, 2020
Mylan Hit With Stock-Drop Suit Over Test Manipulation
A public employee pension fund launched a class action in Pennsylvania federal court on Friday accusing Mylan NV of artificially pumping up its stock price by manipulating quality control tests at a West Virginia plant before eventually being exposed by a pair of whistleblowers and subsequent federal investigations.